ClearPoint Neuro Inc CLPT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
ClearPoint Neuro Reports Second Quarter 2026 Results
-
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel
-
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
-
Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with it
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 30.50M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.54
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 172
- Website
- https://www.clearpointneuro.com
Valuation
|
Metric
|
CLPT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 30.84 |
Price/Sales | 7.54 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CLPT
|
|---|---|
Quick Ratio | 3.66 |
Current Ratio | 4.74 |
Interest Coverage | −5.94 |
Quick Ratio
CLPT
Profitability
|
Metric
|
CLPT
|
|---|---|
Return on Assets (Normalized) | −32.51% |
Return on Equity (Normalized) | −139.82% |
Return on Invested Capital (Normalized) | −32.38% |
Return on Assets
CLPT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|C@w#@d | LOCK|vWk$& | $169B | |||
| Medtronic PLC
MDT
| LOCK|Y^J>?$ | LOCK|?X#Nm | $110B | |||
| Stryker Corp
SYK
| LOCK|>jY@!rW | LOCK|@P> | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|fPCrWlK | LOCK|q?V<G | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|@#r&r^JD | LOCK|gf&dp | $49B | |||
| DexCom Inc
DXCM
| LOCK|<lknSx? | LOCK|!!K#& | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|D@cNgrM | LOCK|v@x | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|r# | LOCK|vQ? | $23B | |||
| Steris PLC
STE
| LOCK|&<N!$% | LOCK|C$??N | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|cBFKJZm | LOCK|&V | $17B |
United States